Prospective Observational Study to Assess Value of Prostate Cancer Diagnostic Methods

Abstract

The purpose of this article is to evaluate the efficiency and effectiveness of analytical and imaging methods for diagnosing prostate cancer in northwest Spain. The authors investigated prospectively two groups of patients with a pathological digital rectal examination (DRE) or prostate-specific antigen (PSA). Sensitivity, specificity, positive predictive value, negative predictive value, receiver operating characteristics curves, and other analyses were performed to determine the relative contributions of PSA, DRE, gray-scale transrectal ultrasonography (TRUS), color Doppler ultrasound (CDUS), symptoms, and patient age to cancer prediction. The presence of prostatic disease symptoms did not distinguish between subjects with and without cancer. The most sensitive (98%) was total PSA (> 4 ng/mL), and the most specific (78%) was DRE and TRUS (65%). The contribution of PSA, DRE, and TRUS to the diagnosis of prostate cancer was significant. In patients with a PSA between 4 and 10 ng/mL, PSA specificity increased, using a free/total PSA ratio of 15%. The PSA continues to be the most sensitive method for prostate cancer diagnosis. DRE tends to be more negative at early stages of cancer detection. Comparing the conventional TRUS echography with the CDUS, the latter is a better detector in the diagnosis of cancer.

Keywords

prostate cancer diagnosis biopsy prostate-specific antigen clinical value

References

1. American Cancer Society : Cancer Facts and Figures— 1992. Atlanta, GA: American Cancer Society, 1992.

2. Vercelli M , Quaglia A , Marani E , Parodi S (EUROCIM 1978–1994): Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol/Hematol 2000;35:133–144.

3. Instituto Nacional de Estadística de España: Defunción según causa de muerte. Estadística del Movimiento Natural de la Población, INE (1960–1997).

4. Okihara K , Kamoi K , Lane RB , Evans RB , Troncoso P , Babaian RJ : Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer. J Clin Ultrasound 2002;30:123–131.

5. Abbas F , Scardino T : The natural history of clinical prostate carcinoma. Cancer 1997;80:827–833.

6. Kirby RS , Christmas TJ , Brawer MK : Prostate Cancer. 2nd ed. St. Louis, MO: C. V. Mosby, 2001.

7. Sperandeo G , Sperandeo M , Morcaldi M , Caturelli E , Dimitri L , Camagna A : Transrectal ultrasonography for the early diagnosis of adenocarcinoma of the prostate: a new maneuver designed to improve the differentiation of malignant and benign lesions. J Urol 2003;169:607–610.

8. Coakley FV , Qayyum A , Kurhanewicz J : Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 2003;170(6, Pt. 2):S69–S76.

9. Kama AM , Rosser CJ , Levy LB , et al: Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure. Urology 2004;63:1132–1137.

10.

10. Hodge KK , McNeal JE , Teriis MK , Stamey TA : Random systematic versus directed ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1989;142:71–77.

11.

11. Gleason DF : Histologic grading of prostate cancer: a perspective. Hum Pathol 1992;23:273–278.

12.

12. Sobin LH , Wittekind CH , eds. UICC: TNM Classification of Malignant Tumors. 5th ed. Berlin: Springer-Verlag, 2000.

13.

13. SPSS : SPSS for Windows. Chicago: SPSS, 1989.

14.

14. Rifkin M : Ultrasound of the Prostate: Imaging in the Diagnosis and Therapy of Prostatic Disease. 2nd ed. Philadelphia: Lippincott-Raven, 1997.

15.

15. Catalona WJ , Richie JP , Ahmann, FR , et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 hombres. J Urol 1994;151:1283–1290.

16.

16. Matlaga BR , Eskew LA , McCullough DL : Prostate biopsy: indications and technique. J Urol 2003;169:12–19.

17.

17. Klinger HC , Woo D , Rosario D , et al: The value of prostate specific antigen (PSA) density and free: total PSA ratio in selecting patients with a normal digital rectal examination and intermediate total PSA levels for further investigation. Br J Urol 1998;82:393–397.

18.

18. Mettlin C , Littrup PL , Kane RA , et al: Sensitivity and specificity of serum PSA level compared with age-referenced PSA, PSA density, and PSA change. Cancer 1994;74:1615–1620.

19.

19. Catalona WJ , Smith DS , Wolfert RL , et al: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1214–1220.

20.

20. Carter HB , Pearson JD , Metter JE , et al: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215–2220.

21.

21. Mettlin C , Lee F , Drago J , Murphy GP , and Investigators of the American Cancer Society National Prostate Cancer Detection Project : Findings on the detection of early prostate cancer in 2425 men. Cancer 1991;67:2949–2958.

22.

22. Rifkin M , McGlynn E , Choi H : Echogenicity of prostate cancer with histologic grade and stromal fibrosis: endorectal US studies. Radiology 1989;170:549–552.

23.

23. McWhorter WP , Hernandez AD , Meikle AW , et al: A screening study prostate cancer in high risk families. J Urol 1992;148:826–831.

24.

24. Bowsher W : Challenges in Prostate Cancer. Oxford, UK: Blackwell, 2000.

25.

25. Roy C , Buy X , Lang H , Saussine CH , Jacqmin D : Contrast enhances color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 2003;170:69–72.

26.

26. Cornud F , Hamida K , Flam T , et al: Endorectal color Doppler sonography and endorectal MR imaging features nonpalpable prostate cancer: correlation with radical prostatectomy findings. Am J Roentgenol 2000;175:1161–1164.

27.

27. Okihara K , Kojima M , Nakanouchi T , Okada K , Miki T : Transrectal power Doppler imaging in the detection of prostate cancer. BJU Int 2000;85:1053–1057.

28.

28. Cornud F , Hamida K , Flam T , et al: Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. Am J Roentgenol 2000;175:1161–1168.

29.

29. Lavoipierre AM , Snow RM , Frydenberg M , et al: Prostatic cancer: role of color Doppler imaging in transrectal sonography. Am J Roentgenol 1998;171:205–210.

30.

30. Franco OE , Arima K , Yanagawa M , Kawaamura J : The usefulness of power Doppler ultrasonography for diagnosing prostate cancer: histological correlation of each biopsy site. BJU Int 2000;85:1049–1052.

31.

31. Mettlin CJ , Murphy GP : Why is the prostate cancer death rate declining in the United States? Cancer 1998;82:249–251.

32.

32. Quinn M , Babb P : Patterns and trends in prostate cancer incidence, survival, prevalence and mortality: Part I. International comparisons. BJU Int 2002;90:162–173.